Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

A turbulent series of events surrounding the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around how the Food and Drug Administration maintains its list of drug ...

Pivotal Peptides says it offers research-grade tirzepatide ... from selling their versions of Eli Lilly's blockbuster weight loss and diabetes drugs. The agency said in a court filing it would ...

Eli Lilly holds the patent for tirzepatide, and while the FDA doesn ... About 1 in 8 Americans have tried a GLP-1 drug for weight loss or diabetes, according to a Kaiser Family Foundation poll.

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

The drugmaker has received approval from the Hong Kong government to sell its tirzepatide injections — branded as Mounjaro — ...

Eli Lilly, a pharmaceutical company ... The pharmaceutical company's popular weight loss drug, Zepbound, has an active ingredient of tirzepatide, which the copycat versions falsely claim to ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Eli Lilly (LLY.N), opens new tab said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss ...

It also said it would not take enforcement action — for now — against pharmacies making their own versions of weight-loss drugs based on Eli Lilly’s tirzepatide, according to a letter it ...